The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly

Mechanisms of Ageing and Development

Volumn 102, Issue 2-3, 1998, Pages 299-306

  Ben Yehuda, A ^a   Danenberg, H D ^a   Zakay Rones, Z ^b   Gross, D J ^a   Friedman, G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Dehydroepiandrosterone (DHEA); Elderly; Influenza vaccine

Indexed keywords

INFLUENZA VACCINE; PLACEBO; PRASTERONE;

AGED; ANTIBODY RESPONSE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION; VOLUNTEER;

ADJUVANTS, IMMUNOLOGIC; AGED; AGING; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLUENZA VACCINES; MALE; VACCINATION;

INFLUENZA VIRUS; INFLUENZAVIRUS A; INFLUENZAVIRUS B;

EID: 0032524998     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(98)00017-7     Document Type: Conference Paper

References (21)

1. Araneo B., Dowell T., Woods M.L.et al. DHEAS as an effective adjuvant in elderly humans. Proof-of-pricinple studies. Ann. N.Y. Acad. Sci. 774:1995;232-248.
2. Barett-Connor E., Khaw K.T., Yen S.S.C. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N. Engl. J. Med. 315:1986;1519-1524.
3. Ben-Yehuda A., Ehlieter D., Hu A.R., Wexler M.E. Recombinant vaccinia virus expressing PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection. J. Inf. Dis. 168:1993;52-57.
4. Beyer W.E.P., Palache A.M., Baldjet M., Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine. 7:1989;385-394.
5. Brandriss M.W., Bets R.F., Mathur U.et al. Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and trivalent A/USSR/77-A/Texas/77 (H3N2)-B/Hong Kong/72 vaccines. Am. Rev. Respir. Dis. 124:1981;681-684.
6. Casson P.R., Andersen R.N., Henry G.H.et al. Oral dehydroepiandrosterone in physiologic doses modulates immune function in post-menopausal women. Am. J. Obstet. Gynecol. 169:1993;1536-1539.
7. Danenberg H.D., Ben-Yehuda A., Zakay-Rones Z., Friedman G. Dehydroepiandrosterone reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine. 15:1995;1445-1448.
8. Daynes R.A., Araneo B.A. Prevention and reversal of some age-associated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging: Immunol. Inf. Dis. 3:1992;135-154.
9. Effros R.B., Pawelec G. Replicative senescence of T-cells does the Hayflick limit lead to immune exhaustion. Immunol Today. 18:1997;450-454.
10. Evans T.G., Judd M.E., Dowell T., Poe S., Daynes R.A., Araneo B.A. The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly. Vaccine. 14:1996;1531-1537.
11. Gordon G.B., Bush D.E., Weisman H.F. Reduction of atherosclerosis by administration of dehydroepiandrosterone: a study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. J. Clin. Invest. 82:1988;712-720.
12. Govaert T.M.E., Sprenger M.J.W., Dinant G.J.et al. Immune response to influenza vaccination of elderly people: A randomized double blind placebo-controlled trial. Vaccine. 12:1994;1185-1189.
13. Gross P.A., Hermogenes A.W., Sacks H.S.et al. The efficacy of influenza vaccine in the elderly, a meta-analysis and review of the literature. Arch. Int. Med. 123:1995;518-527.
14. Hoskins T.W. Assessment of inactivated influenza A vaccine after three outbreaks of influenza at Christ's Hospital. Lancet. 1:1979;33-35.
15. Keitel W.A., Cate R., Couch R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am. J. Epidemiol. 127:1988;353-364.
16. Kohn R.P. Cause of death in very old people. J. Am. Med. Assoc. 247:1982;2793-2797.
17. Ratko T.A., Detrisac C.J., Mehta R.G.et al. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Cancer Res. 51:1991;481-486.
18. Remarque E.J., van-Beek W.C., Ligthart G.J.et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing home residents by the use of high dose vaccines. Vaccine. 11:1993;649-654.
19. Setia U., Serventi I., Lorenz P. Factors affecting the use of influenza vaccine in institutionalized elderly. J. Am. Geriatr. Soc. 33:1985;856-858.
20. Van-Vollenhoven R.F., Engleman E.G., McGuire J.L. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 37:1994;1305-1310.
21. van-Weerden W.M., Bierings H.G., van-Steenbrugge G.J.et al. Adrenal glands of mouse and rat do not synthesize androgens. Life Sci. 50:1992;857-861.